Vtgn stock forecast.

In addition, VistaGen has granted the underwriter a 45-day option to purchase up to an additional 2,343,750 shares of common stock at the per share public offering price, less discounts and ...VistaGen Therapeutics Inc stock price live 3.650, this page displays NASDAQ VTGN stock exchange data. View the VTGN premarket stock price ahead of the market session or assess the after hours quote.Discover historical prices for VTGN stock on Yahoo Finance. View daily, weekly or monthly format back to when Vistagen Therapeutics, Inc. stock was issued.Oct 15, 2020 · VistaGen Therapeutics (VTGN) stock price prediction is 4.1549132874741 USD. The VistaGen Therapeutics stock forecast is 4.1549132874741 USD for 2024 November 29, Friday; and 6.863 USD for 2028 November 29, Wednesday with technical analysis. Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

VTGN technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of VistaGen Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more.

Complete VistaGen Therapeutics Inc. stock information by Barron's. View real-time VTGN stock price and news, along with industry-best analysis.Nov 30, 2023 · Vistagen Therapeutics Stock Price, News & Analysis (NASDAQ:VTGN) $3.65 +0.06 (+1.67%) (As of 12/1/2023 ET) Compare Today's Range $3.47 $3.68 50-Day Range $2.57 $5.36 52-Week Range $1.62 $24.71 Volume 224,227 shs Average Volume 572,470 shs Market Capitalization $98.62 million P/E Ratio N/A Dividend Yield N/A Price Target $21.00

Jun 30, 2023 · NasdaqCM:VTGN Stock Report. Mkt Cap: US$75.3m. Add to watchlist. Company Overview; 1 Valuation; ... Consensus forecasts updated Aug 18. Forecast to breakeven in 2025 ... The SEC requires all publicly traded companies, foreign and domestic, to disclose financial condition, operating results, management compensation, and other areas of their business on a regular ...For VistaGen Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average VistaGen Therapeutics stock forecast of $4.98, a high forecast of $6.23, and a low forecast of $3.42. The average VistaGen Therapeutics stock forecast 2031 represents a 44.91% increase from the last price of $3.44000005722046.August 7, 2023 at 1:12 PM PDT. Listen. 2:12. A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its ...

Jul 20, 2022 · (See VTGN stock forecast on TipRanks) Oyster Point Pharma . The second stock we’ll look at is another biopharma, one in both the clinical and commercialization stages. Oyster Point is working on ...

(See VTGN stock forecast on TipRanks) Oyster Point Pharma . The second stock we’ll look at is another biopharma, one in both the clinical and commercialization stages. Oyster Point is working on ...

William Blair initiated coverage on VistaGen Therapeutics Inc (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing next …Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...Find real-time IMGN - ImmunoGen Inc stock quotes, company profile, news and forecasts from CNN Business. On August 22, 2023, Vistagen Therapeutics Inc (VTGN) experienced a significant surge in its stock performance following positive analyst forecasts. According to data sourced from CNN Money, the one analyst offering a 12-month price forecast for VTGN has set a median target of $30.00, with both the high and low estimates also at $30.00.We would like to show you a description here but the site won’t allow us.Dec 1, 2023 · VTGN Signals & Forecast. The VistaGen Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.

Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.About the VistaGen Therapeutics, Inc. stock forecast. As of 2023 November 29, Wednesday current price of VTGN stock is 3.600$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. VistaGen Therapeutics stock price as been showing a rising tendency so we believe …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...On average, Wall Street analysts predict that Vistagen Therapeutics 's share price could reach $21.00 by Nov 14, 2024. The average Vistagen Therapeutics stock price …Back to VTGN Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Overview News Ideas Financials Technicals Forecast VTGN chart Today 0.00% 5 days 8.85% 1 month 20.20% 6 months −12.98% Year to date 14.73% 1 year −18.08% 5 years −93.29% All time −99.75% Key stats …

Nov 29, 2023 · See the latest Vistagen Therapeutics Inc stock price (VTGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul. 22, 2022-- VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today …

See the latest Vistagen Therapeutics Inc stock price (VTGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Stock Quote & Chart; Historical Data; Press Releases; Events; SEC Filings All SEC Filings; Annual Reports; Quarterly Results; Section 16 Filings; Corporate Governance ... 2023-- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comAugust 7, 2023 at 1:12 PM PDT. Listen. 2:12. A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its ...The Smith Micro Software stock price fell by -2.26% on the last day (Monday, 6th Nov 2023) from $1.11 to $1.08. During the last trading day the stock fluctuated 5.66% from a day low at $1.06 to a day high of $1.12. The price has risen in 6 of the last 10 days and is up by 4.85% over the past 2 weeks. Volume has increased on the last day …Aug 7, 2023 · August 7, 2023 at 1:12 PM PDT. Listen. 2:12. A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its ... Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. Overview News Ideas Financials Technicals Forecast VTGN chart Today 7.16% 5 days 8.13% 1 month 20.07% 6 months −11.84% Year to date 11.62% 1 year −16.17% 5 years −92.84% All time −99.76% Key stats Market capitalization 97.013M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −4.71 USD Net income −59.248M USD Revenue 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Vistagen Therapeutics, Inc. (VTGN) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 3.6500 +0.0600 (+1.67%) At...

Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.

About the VistaGen Therapeutics, Inc. stock forecast. As of 2023 November 29, Wednesday current price of VTGN stock is 3.600$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).

Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other CNS disorders. Vistagen is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those currently available for …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...OceanaGold (OCANF) Stock Forecast & Price Target - TipRanksFor VistaGen Therapeutics Inc Stock (VTGN) price forecast for 2024, the average price target for VistaGen Therapeutics Inc Stock is $2.9295 with a high forecast of $3.6023 and a low forecast of $2.2567. The average VTGN price prediction of 2024 represents a -18.40% decrease from the last price of $3.59. Is Vistagen Therapeutics Inc (VTGN) Stock a Good Investment? By Sean Murphy September 29, 2023 . Featured Tickers: VTGN. Learn more about whether Vistagen Therapeutics Inc is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how grades on certain investment factors and …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comNov 30, 2023 · View VistaGen Therapeutics, Inc VTGN investment & stock information. Get the latest VistaGen Therapeutics, Inc VTGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.VistaGen's history tends to make investors cautious with 2012 stock price highs of >$60/share to lows of $0.32/share. ... Thanks for your report-VTGN has been a significant hold for a few years ...SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun. 6, 2023-- Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that it will implement a …

About Us Committed to developing a new generation of CNS medicines that go beyond the current standard of care. Vistagen is developing an innovative pipeline of Central Nervous System (CNS) medications with the potential to establish new standards of care in the treatment of a variety of serious anxiety, depression and other CNS disorders that are disrupting the lives of tens of millions of ... VTGN | Complete VistaGen Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Aug 22, 2023 · On August 22, 2023, Vistagen Therapeutics Inc (VTGN) experienced a significant surge in its stock performance following positive analyst forecasts. According to data sourced from CNN Money, the one analyst offering a 12-month price forecast for VTGN has set a median target of $30.00, with both the high and low estimates also at $30.00. Instagram:https://instagram. lead penny worthfutures brokers low marginday trading courses for beginnershigh yeild stocks Tenet Healthcare Corp. [THC] stock is trading at $63.74, up 9.63%. One of the good ways to gauge the recent performance is if the stock's short-term value is rising or falling. The THC shares have gain 18.50% over the last week, with a monthly amount glided 12.95%, and seem to be holding up well over ... (VTGN) stock forecast: Can it reach its …The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the... non qm loan lendersdefense company stocks Jul 6, 2023 · Analyst Price Forecast Suggests 53.10% Downside As of July 6, 2023, the average one-year price target for VistaGen Therapeutics is 6.12. The forecasts range from a low of 6.06 to a high of $6.30. ১৫ সেপ, ২০২২ ... Furthermore it explains you the vtgn stock forecast and how to do vtgn stock prediction. It will also help you to understand whether ... personal inventory app Find the latest VistaGen Therapeutics, Inc. VTGN analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. report ... Get Vistagen Therapeutics Inc (VTGN.C) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.The 12-month stock price forecast is $21.0, which is an increase of 526.87% from the latest price. Price Target $21.0 ( 526.87% upside) Analyst Consensus: …